Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population-Reference-Cited by-同舟云学术

Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population

Published:2015-12-17 Issue:12 Volume:10 Page:e0144731
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ying Jianming,Lin Chen,Wu Jian,Guo Lei,Qiu Tian,Ling Yun,Shan Ling,Zhou Haitao,Zhao Dongbing,Wang Jian,Liang Jianwei,Zhao Jianjun,Jiao Yuchen,Lu Ning,Zhao Hong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Fusion of a kinase gene, alk, to a nucleolar protein gene, npm, in non-hodgkin's lymphoma;SW Morris;Science,1994

2. Identification of new alk and ret gene fusions from colorectal and lung cancer biopsies;D Lipson;Nat Med,2012

3. Diagnostic value of a novel fully automated immunochemistry assay for detection of alk rearrangement in primary lung adenocarcinoma;J Ying;Ann Oncol,2013

4. Alk1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor;CM Coffin;Modern Pathol,2001

5. Identification of squamous cell carcinoma associated proteins by proteomics and loss of beta tropomyosin expression in esophageal cancer;FR Jazii;World J Gastroenterol,2006

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review;The Oncologist;2024-02-21

2. ALK fusions in the pan-cancer setting: another tumor-agnostic target?;npj Precision Oncology;2023-09-29

3. Ditercalinium chloride: A potential inhibitor targeting recurrent in frame COMMD10-AP3S1 fusions in CRCs;Gene Reports;2023-03

4. SPTBN1 abrogates renal clear cell carcinoma progression via glycolysis reprogramming in a GPT2-dependent manner;Journal of Translational Medicine;2022-12-16

5. Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer;Pharmaceutics;2022-09-01